MedPath

Omniactive Health Technologies

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

12

Active:0
Completed:9

Trial Phases

1 Phases

Not Applicable:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (100.0%)
No trials found

News

FDA Grants GRAS Clearance for OmniActive's Lutemax Free Lutein in Infant Formula

The FDA acknowledged OmniActive's Lutemax Free Lutein for use in infant formula through GRAS clearance, marking a significant regulatory milestone for early life nutrition.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.